✦ LIBER ✦

Thrombotic Microangiopathy With Tacrolimus/Sirolimus-Based GVHD Prophylaxis Regimen in Patients Undergoing Hematopoietic Stem Cell Transplant

✍ Scribed by S. Shayani; J. Palmer; T. Stiller; R. Rodriguez; T. Khuu; P.M. Parker; D.S. Snyder; V. Pullarkat; J. Rosenthal; A. Nademanee; D. Senitzer; S.J. Forman; S. Khaled; R. Nakamura

Book ID: 116282361
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 79 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.12.425

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced intensity allogeneic hematopoiet

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

✍ Ryotaro Nakamura; Joycelynne M. Palmer; Margaret R. O’Donnell; Tracey Stiller; S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 272 KB

A phase II pilot study of tacrolimus/sir

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

✍ Rodriguez, R.; Nakamura, R.; Palmer, J. M.; Parker, P.; Shayani, S.; Nademanee, 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 260 KB

Pulmonary Hypertension (PH) in Patients

Pulmonary Hypertension (PH) in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TMA)

✍ S. Jodele; R. Chima; K. Hor; D. Witte; B.L. Laskin; J. Goebel; K.C. Mayers; P.A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Response: A phase II pilot study of tacr

Response: A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 different conditioning regimens

✍ Nakamura, R.; Rodriguez, R.; Shayani, S.; Parker, P.; Forman, S. J. 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 147 KB

Sirolimus, Tacrolimus, And Rabbit ATG (r

Sirolimus, Tacrolimus, And Rabbit ATG (rATG) As Graft-Versus-Host Prophylaxis In Patients Undergoing Unrelated Donor Hematopoietic Stem Cell Transplant (HCT)

✍ S.K. Khaled; J. Palmer; P. Parker; A. Nademanee; V. Pullarkat; J.-L. Cai; D. Sny 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Significant Adverse Effects Associated w

Significant Adverse Effects Associated with Sirolimus/Tacrolimus GVHD Prophylaxis Regimen (Siro-tac) in Allogeneic Hematopoeitic Stem Cell Transplant (alloHSCT) Patients (pts): A Single Institution Experience

✍ S. Nathan; J.J. Maciejewski; E.S. Rich; S.A. Gregory; K. Schultz; H.C. Fung 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB